Original price was: ₹4,265.00.₹1,500.00Current price is: ₹1,500.00.
U Tryp 100000IU Injection serves to treat severe sepsis. It also addresses acute pancreatitis, which involves inflammation of the pancreas. The injection works by lowering the levels of chemicals that drive inflammation. In this way, it aids the recovery process for patients facing these conditions.
Salt/Formula: Ulinastatin (100000IU)
Manufacturer: Bharat Serums & Vaccines Ltd
Dosage: 100000IU
U Tryp 100000IU Injection works in cases of severe sepsis. It helps control the inflammation that comes from this life-threatening infection. The drug reduces those harmful chemicals at play. That way it manages the symptoms better. Doctors give it in a hospital setting.
U Tryp 100000IU Injection also treats pancreatitis. It eases the pain and swelling in the pancreas. This prevents more damage from happening. It even promotes healing over time.
Your doctor or nurse will administer this medicine to you. Do not try to give it to yourself in any situation.
Your doctor or nurse will administer this medicine to you. Do not try to give it to yourself in any situation.
Most side effects turn out to be short term. They often do not call for any medical care. This happens as your body gets used to the medication. Still, if those effects keep going or if they worry you at all, make sure to talk with your doctor.
Common side effects from U Tryp cover things like reactions at the injection site. Those can mean pain, swelling, or redness there. Elevated liver enzymes show up too.
U Tryp 100000IU Injection helps manage severe sepsis and acute pancreatitis. It does this by lowering the chemicals that lead to inflammation in the pancreas. A doctor or nurse will give you the injection. They adjust the dose based on your specific situation. Stick with the full course of treatment as directed. This helps keep symptoms from coming back. Make sure to tell your doctor about all other medicines you happen to be using.
Select at least 2 products
to compare
Reviews
There are no reviews yet.